Wedgewood, the nation’s largest provider of compounded veterinary medications and pharmacy solutions, has announced the appointment of Dr. Rae Hutchins, DVM, DACVIM (SAIM), as its inaugural Chief Veterinary Officer. This landmark decision underscores Wedgewood’s commitment to enhancing its partnerships with veterinarians and advancing the standard of veterinary care.

Wedgewood Pharmacy has launched compounded molnupiravir for the treatment of Feline Infectious Peritonitis (FIP), offering a new option for veterinarians and cat owners. Available in flavored oral suspensions and capsules, this innovative formulation addresses the various forms of FIP and represents a major advancement in feline health. Learn more about this promising new treatment and how it’s transforming FIP care.